Cargando…

The antiplatelet agent revacept prevents the increase of systemic thromboxane A(2) biosynthesis and neointima hyperplasia

Neointima hyperplasia is a crucial component of restenosis after coronary angioplasty. We have hypothesized that enhanced generation of platelet-derived thromboxane (TX)A(2) in response to vascular damage plays a critical role in neointimal hyperplasia and that antiplatelet agents may mitigate it. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alberti, Sara, Zhang, Qianqian, D’Agostino, Ilaria, Bruno, Annalisa, Tacconelli, Stefania, Contursi, Annalisa, Guarnieri, Simone, Dovizio, Melania, Falcone, Lorenza, Ballerini, Patrizia, Münch, Götz, Yu, Ying, Patrignani, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722842/ https://www.ncbi.nlm.nih.gov/pubmed/33293599 http://dx.doi.org/10.1038/s41598-020-77934-x

Ejemplares similares

Antithrombotic Agents and Cancer
por: Bruno, Annalisa, et al.
Publicado: (2018)

Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System
por: Dovizio, Melania, et al.
Publicado: (2020)

Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis
por: Rovati, Gianenrico, et al.
Publicado: (2022)

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients
por: Lanas, Angel, et al.
Publicado: (2023)

P2Y(12) Receptors in Tumorigenesis and Metastasis
por: Ballerini, Patrizia, et al.
Publicado: (2018)

Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
por: Ballerini, Patrizia, et al.
Publicado: (2022)

Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro
por: Hofling, Ulrika, et al.
Publicado: (2022)

Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke
por: Reimann, Andreas, et al.
Publicado: (2016)

The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke
por: Goebel, Silvia, et al.
Publicado: (2013)

Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells
por: Contursi, Annalisa, et al.
Publicado: (2023)

Platelets induce free and phospholipid-esterified 12-hydroxyeicosatetraenoic acid generation in colon cancer cells by delivering 12-lipoxygenase
por: Contursi, Annalisa, et al.
Publicado: (2021)

Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Artery Stenosis: Design and Rationale of a Randomized Phase II Clinical Trial
por: Gröschel, Klaus, et al.
Publicado: (2020)

The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times
por: Ungerer, Martin, et al.
Publicado: (2013)

Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent
por: Dovizio, Melania, et al.
Publicado: (2012)

Thromboxane A(2) Receptor Stimulation Promotes Closure of the Rat Ductus Arteriosus through Enhancing Neointima Formation
por: Yokota, Tomohiro, et al.
Publicado: (2014)

Novel Insights into the Vasoprotective Role of Heme Oxygenase-1
por: Marcantoni, Emanuela, et al.
Publicado: (2012)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

Time for Integrating Clinical, Lifestyle and Molecular Data to Predict Drug Responses
por: Patrignani, Paola, et al.
Publicado: (2016)

Grand Challenges in Pharmacotherapy of Inflammation for the First Decades of the 21st Century
por: Patrignani, Paola, et al.
Publicado: (2010)

Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling
por: Unsworth, Amanda J., et al.
Publicado: (2020)

Antiplatelet Effect of Daphnetin Is Regulated by cPLA(2)-Mediated Thromboxane A(2) Generation in Mice
por: Chaudhary, Preeti Kumari, et al.
Publicado: (2023)

Pharmacological Characterization of the Microsomal Prostaglandin E(2) Synthase-1 Inhibitor AF3485 In Vitro and In Vivo
por: Di Francesco, Luigia, et al.
Publicado: (2020)

Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor
por: Cong, Yue, et al.
Publicado: (2016)

Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk
por: Dovizio, Melania, et al.
Publicado: (2015)

Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells
por: Guillem-Llobat, Paloma, et al.
Publicado: (2016)

Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994)

Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019)

Antiplatelet Effect of Catechol Is Related to Inhibition of Cyclooxygenase, Reactive Oxygen Species, ERK/p38 Signaling and Thromboxane A(2) Production
por: Chang, Mei-Chi, et al.
Publicado: (2014)

Measurement of Thromboxane Biosynthesis in Health and Disease
por: Patrono, Carlo, et al.
Publicado: (2019)

NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
por: Afzal, Tayyab Adeel, et al.
Publicado: (2016)

Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima
por: Hwang, Ae-Rang, et al.
Publicado: (2023)

Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010)

Uremia does not affect neointima formation in mice
por: Aarup, Annemarie, et al.
Publicado: (2017)

Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer
por: Watkins, Gareth, et al.
Publicado: (2005)

Foetal vascular responses to thromboxane receptor blockade
por: Meyer, B. A., et al.
Publicado: (1992)

Prostacyclin and thromboxane in benign and malignant breast tumours.
por: Laekeman, G. M., et al.
Publicado: (1986)

Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia
por: Zhang, Li, et al.
Publicado: (2017)

Inhibition of Neointima Hyperplasia, Inflammation, and Reactive Oxygen Species in Balloon-Injured Arteries by HVJ Envelope Vector-Mediated Delivery of Superoxide Dismutase Gene
por: Lin, Shoa-Lin, et al.
Publicado: (2018)

ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction
por: Trigani, Kevin T., et al.
Publicado: (2022)

Neointima development in externally stented saphenous vein grafts
por: Węglarz, Przemysław, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vado7m2sjmpebofh03kaoevp28